Prof. Li Min’s research postgraduate student Mr. Sandeep Malampati from Mr. & Mrs. Ko Chi Ming Centre for Parkinson's Disease Research has passed his Ph.D. thesis Oral examination on 20th-December-2019. He has done astounding research work on an Alzheimer’s disease (AD) treating drug, C1. Previously, Prof. Li Min’s research team has identified this compound as a novel autophagy activator. Mr. Sandeep, in his Ph.D. dissertation work, has ascertained the anti-AD activity of C1 in vitro and in multiple in vivo experimental models. This work has been published in the prestigious peer-reviewed journal Aging Cell. The research team is looking forward to developing this compound further as a clinically competitive therapeutic agent for treating AD patients.

   Mr. Sandeep Malampati and the oral examination board members.

(Left to right): Dr. Cheung King Ho, Associate Professor of the School of Chinese Medicine, Hong Kong Baptist University; Prof Chen Hubiao, Professor of the School of Chinese Medicine, Hong Kong Baptist University; Prof. Shen Jiangang, Associate Director of the School of Chinese Medicine, University of Hong Kong; Mr. Sandeep Malampati; Prof. Li Min, Sandeep’s principal supervisor, Associate Dean of School of Chinese Medicine, Hong Kong Baptist University, Director of Mr. & Mrs. Ko Chi Ming Centre for Parkinson's Disease Research; Dr. Han Quanbin, Assistant Professor of the School of Chinese Medicine, Hong Kong Baptist University; and Dr. Kwan Hiu Yee, Assistant Professor of the School of Chinese Medicine, Hong Kong Baptist University.